Table 7.
Prediction of life expectancy in men with clinically localized prostate cancer
Reference | Year | Prediction form | Outcome | No of Patients | Variables | Discrimination | Validation |
---|---|---|---|---|---|---|---|
Albertson et al. [95] | 1996 | Probability formula | Overall survival (10 years) | 451 | Age, Gleason sum and index of coexistent disease category | 71% | Not performed |
Tewari et al. [93] | 2004 | Probability graph | Overall survival (10 years) | 6149 | Age, race, comorbidity, PSA, Gleason sum, treatment type | 63% | Not performed |
Cowen et al. [94] | 2006 | Probability nomogram development | Life expectancy (5–15 years) | 506 | Age, Charlson comorbidity index, presence of angina, systolic blood pressure, body mass index, smoking, marital status, PSA< Gleason sum, clinical stage, treatment type (radical prostatectomy vs radiotherapy vs other) | 73% | Internal |
Walz et al. [97] | 2007 | Probability nomogram development | Life expectancy (10 years) | 9131 (5,955 treated with radical prostatectomy and 3,176 with external beam radiotherapy) | Age, Charlson comorbidity index, treatment type (radical prostatectomy vs external beam radiotherapy) | 84.3% | Internal |